WONCA Europe is pleased to share a historic piece of good news from the 79th World Health Assembly (WHA79) in Geneva. Delegates have officially approved the landmark resolution recognizing steatotic liver disease (SLD)—formerly referred to as fatty liver disease—as an urgent and expanding global noncommunicable disease (NCD) challenge.
As a proud member of the European Health Alliance on Alcohol (EHAA), WONCA Europe strongly endorsed the statement submitted by the Alliance in support of the WHO draft resolution. Together with our partners, we welcomed this vital step to bring a long-neglected family of chronic conditions into the mainstream global health agenda.
🩺 Why this Matters for Family Medicine and Primary Care
SLD is estimated to affect roughly 1.7 billion people worldwide, making it one of the fastest-growing causes of chronic liver disease globally. Crucially, SLD does not exist in isolation. It is deeply intertwined with obesity, type 2 diabetes, cardiovascular disease, and other metabolic conditions, while alcohol-associated liver disease continues to contribute heavily to the overall global burden.
Because early-stage SLD is frequently asymptomatic, family doctors and primary care teams are on the absolute frontline of defence. Without proactive early screening, risk assessment, and lifestyle interventions, SLD can silently progress to advanced fibrosis, cirrhosis, and liver cancer—placing monumental strain on individuals and healthcare infrastructure alike.
📋 Key Pillars of the WHA Resolution
The newly adopted resolution explicitly calls upon WHO Member States to:
-
Integrate SLD into national NCD strategies and health system planning alongside established priorities like heart disease and diabetes.
-
Strengthen primary health care (PHC) approaches, surveillance systems, and public awareness to facilitate early detection and routine risk tracking.
-
Take multisectoral action on shared risk factors, specifically targeting unhealthy diets, physical inactivity, and the harmful use of alcohol.
🌐 Expanding the Policy Space for Prevention
For general practitioners and public health advocates across Europe, this development opens crucial new pathways for advocacy. By formally positioning liver health within the broader NCD response, the resolution creates vital additional policy space. Measures targeting the commercial and social determinants of health—such as alcohol regulation and fiscal health taxes—are no longer siloed solely under "alcohol policy." Instead, they are recognized as pillars of integrated NCD and liver health strategies.
WONCA Europe celebrates this monumental policy shift. We urge health ministries across the European region to swiftly translate their votes into action by embedding liver health indicators into primary care guidelines and national health frameworks. By strengthening the upstream capabilities of general practice, we can move from managing late-stage organ failure to preventing chronic metabolic disease at its roots.
🔗 Useful Links
-
Discover more about our joint public health advocacy at the European Health Alliance on Alcohol (EHAA) Website.
-
For full details on the resolution, read the official WHO World Health Assembly Daily Update.